Harrow Health Inc. 11.875... (HROWM)
Harrow Health 11.875% Senior Notes due 2027 Statistics
Share Statistics
Harrow Health 11.875% Senior Notes due 2027 has 41.28M shares outstanding. The number of shares has increased by 163.39% in one year.
| 41.28M |
| 163.39% |
| -20.49% |
| n/a |
| 35.64M |
| n/a |
| n/a |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Enterprise Valuation
Harrow Health 11.875% Senior Notes due 2027 has an Enterprise Value (EV) of 957.93M.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of undefined.
| 2.82 |
| 2.6 |
| n/a |
| n/a |
| n/a |
| undefined |
Financial Efficiency
Return on Equity is -0.34% and Return on Invested Capital is 0.17%.
| -0.34% |
| -0.08% |
| 0.17% |
| $599,967.74 |
| $-112,493.09 |
| 217 |
| 0.42 |
| 3.65 |
Taxes
| 701K |
| -0.03% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.17, so Harrow Health 11.875% Senior Notes due 2027's price volatility has been higher than the market average.
| 0.17 |
| n/a |
| 26.34 |
| 26.36 |
| 48.02 |
| n/a |
Income Statement
In the last 12 months, Harrow Health 11.875% Senior Notes due 2027 had revenue of 130.19M and earned -24.41M in profits. Earnings per share was -0.75.
| 130.19M |
| 90.55M |
| 431K |
| -24.41M |
| 9.72M |
| 431K |
| -0.75 |
Balance Sheet
The company has 74.08M in cash and 190.5M in debt, giving a net cash position of -116.42M.
| 74.08M |
| 190.5M |
| -116.42M |
| -133.9M |
| 306.63M |
| 85.39M |
Cash Flow
In the last 12 months, operating cash flow was 3.84M and capital expenditures -1.46M, giving a free cash flow of 2.38M.
| 3.84M |
| -1.46M |
| 2.38M |
| 0.07 |
Margins
Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.
| 69.55% |
| 0.33% |
| -18.21% |
| -18.75% |
| 7.47% |
| 0.33% |
| 1.83% |
Dividends & Yields
HROWM does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 2.78 |
| 3 |